Scopio Labs has formally launched its full-field peripheral blood smear (PBS) application on the firm's X100 platform. The application combines full-field imaging and an artificial intelligence-based decisions-support system with remote capabilities.
Designed for hematology labs, the new application features adaptive monolayer identification for analysis. It supports short and long smears, white blood cell detection, preclassification and quantification into 16 classes, red blood cell morphology evaluation from 1,000 fields of view, and automated platelet location and preestimation, the company said.
Scopios said that a recent study showed the software yielded a 60% improvement in turnaround time for the analysis of peripheral blood smear samples. The application received U.S. Food and Drug Administration clearance in October 2020.